AbGn-134

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug NameAbGn-134
Drug Alias Nameantibody-134
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsAutoimmune DiseasesLymphoma, B-Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAltrubio Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAltrubio Inc
Active IndicationsN/A
Inactive IndicationsAutoimmune DiseasesLymphoma, B-Cell

Other Information

ATC CodeN/A
Related LinksN/A